You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Palivizumab

Showing 26 - 50 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Respiratory Syncytial Virus Infections Trial in Worldwide (RSV vaccine GSK3003895A (formulation 1), RSV vaccine GSK3003898A

Completed
Has Results
  • Respiratory Syncytial Virus Infections
  • RSV vaccine GSK3003895A (formulation 1)
  • +3 more
  • Mesa, Arizona
  • +11 more
May 31, 2018

Depression, Child Development Trial in Boston (Problem Solving Education tailored to NICU)

Completed
  • Depression
  • Child Development
  • Problem Solving Education tailored to NICU
  • Boston, Massachusetts
  • +3 more
Aug 24, 2018

Program to Assess Respiratory Syncytial Virus Hospitalization

Completed
Has Results
  • Respiratory Syncytial Virus (RSV)
    • (no location specified)
    Jun 29, 2016

    Respiratory Syncytial Virus Trial in Worldwide (MEDI7510, IIV, Placebo)

    Terminated
    Has Results
    • Respiratory Syncytial Virus
    • MEDI7510
    • +2 more
    • Sacramento, California
    • +60 more
    Dec 22, 2017

    Respiratory Syncytial Virus Infections Trial in Finland, Spain, United States (RSV vaccine (GSK3003891A) formulation 1, RSV

    Withdrawn
    • Respiratory Syncytial Virus Infections
    • RSV vaccine (GSK3003891A) formulation 1
    • +3 more
    • Newton, Kansas
    • +11 more
    Oct 12, 2018

    Respiratory Syncytial Virus Infections Trial in Worldwide (Suptavumab 30 mg/kg, Placebo Matched to Suptavumab, Suptavumab 30

    Completed
    Has Results
    • Respiratory Syncytial Virus Infections
    • Suptavumab 30 mg/kg
    • +3 more
    • Birmingham, Alabama
    • +204 more
    Oct 8, 2018

    Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special

    Completed
    Has Results
    • Respiratory Syncytial Virus Infection
      • (no location specified)
      Feb 10, 2017

      Respiratory Syncytial Virus Trial in Chile, South Africa, United States (Placebo, MEDI8897 10 mg, MEDI8897 25 mg)

      Completed
      Has Results
      • Respiratory Syncytial Virus
      • Placebo
      • +3 more
      • Anaheim, California
      • +12 more
      Sep 18, 2018

      Palivizumab Administration in Children Born at 29-32 Weeks of

      Completed
      • Bronchial Hyperreactivity
      • Infant, Premature
      • Methacholine Challenge Test (MCT)
      • +4 more
      • Haifa, Israel
        Rambam Medical Center
      Nov 8, 2015

      Pain Trial in Surrey (tetracaine 4% gel, Placebo)

      Completed
      Has Results
      • Pain
      • tetracaine 4% gel
      • Placebo
      • Surrey, British Columbia, Canada
        Surrey Memorial Hospital
      May 22, 2015

      Respiratory Syncytial Virus Infections Trial in United States (Low dose RSV F Antigen, High dose RSV F Antigen, Dose 1 of

      Completed
      • Respiratory Syncytial Virus Infections
      • Low dose RSV F Antigen
      • +6 more
      • Walnut Creek, California
      • +9 more
      Apr 27, 2016

      Respiratory Infections Trial in Buenos Aires (Human donor milk)

      Completed
      • Respiratory Infections
      • Human donor milk
      • Buenos Aires, Argentina
        Fundacion INFANT
      Feb 13, 2017

      Respiratory Syncytial Virus Infection in Latin America

      Completed
      Has Results
      • Respiratory Syncytial Virus Infection
        • Buenos Aires, Argentina
        • +23 more
        Sep 19, 2014

        Respiratory Syncytial Virus Infection During Infancy on Later

        Completed
        • Atopic Asthma
        • Recurrent Wheezing
          • (no location specified)
          Dec 5, 2014

          Surveillance of Synagis in Korean Pediatric Patients

          Completed
          Has Results
          • Respiratory Syncytial Virus Infection
            • (no location specified)
            Jun 18, 2015

            Respiratory Syncytial Virus Infection Trial in Japan (Palivizumab)

            Completed
            Has Results
            • Respiratory Syncytial Virus Infection
            • Palivizumab
            • Hyogo, Japan
            • +5 more
            Jun 13, 2013

            Motavizumab Administration for a Second Season for RSV Prophylaxis Trial in Porto Alegre, Ribeirao Preto, Santiago (motavizumab

            Completed
            Has Results
            • Motavizumab Administration for a Second Season for RSV Prophylaxis
            • motavizumab (MEDI-524)
            • palivizumab 15 mg/kg
            • Porto Alegre, Brazil
            • +5 more
            Apr 3, 2013

            Respiratory Syncytial Virus Infections Trial in Worldwide (motavizumab (MEDI-524), palivizumab)

            Completed
            Has Results
            • Respiratory Syncytial Virus Infections
            • motavizumab (MEDI-524)
            • palivizumab
            • Birmingham, Alabama
            • +343 more
            Jun 21, 2013

            Respiratory Syncytial Virus Infections, Chronic Lung Disease and <= 24 Months of Age or, Premature With Gestational Age <=35

            Completed
            Has Results
            • Respiratory Syncytial Virus Infections
            • +2 more
            • Motavizumab, palivizumab
            • +2 more
            • Garran, Australian Capital Territory, Australia
            • +18 more
            Nov 13, 2012

            Synagis Immunoprophylaxis in Preterm Infants With High Risk of

            Completed
            Has Results
            • Respiratory Syncytial Virus Infection
            • Synagis (palivizumab), monoclonal antibody for passive immunoprophylaxis against severe RSV disease administered according to usual clinical practice.
            • Arequipa, Peru
            • +3 more
            Oct 26, 2012

            Synagis Under Daily Pediatrician´s Conditions in Premature

            Completed
            Has Results
            • Premature Infants
              • Amstetten, Austria
              • +44 more
              Aug 20, 2012

              Palivizumab on Later Recurrent Wheezing in Preterm Infants

              Completed
              • Recurrent Wheezing
              • +2 more
                • Shinjuku, Tokyo, Japan
                  Tokyo Women's Medical University
                Apr 1, 2012

                Respiratory Syncytial Virus Infection, Premature Birth, Bronchopulmonary Dysplasia Trial in Russian Federation (palivizumab)

                Completed
                Has Results
                • Respiratory Syncytial Virus Infection
                • +3 more
                • palivizumab
                • Ivanovo, Russian Federation
                • +18 more
                Jun 21, 2011

                Congenital Heart Disease Trial in Worldwide (Motavizumab, Palivizumab)

                Completed
                Has Results
                • Congenital Heart Disease
                • Motavizumab
                • Palivizumab
                • Little Rock, Arkansas
                • +152 more
                Feb 14, 2012

                Hemodynamically Significant Congenital Heart Disease

                Completed
                Has Results
                • Severe Respiratory Syncytial Virus Infection
                  • Linz, Austria
                  • +36 more
                  Mar 18, 2011